Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Shimura, Hideki, Hattori, Nobutaka, Kubo, Shin-ichiro, Mizuno, Yoshikuni, Asakawa, Shuichi, Minoshima, Shinsei, Shimizu, Nobuyoshi, Iwai, Kazuhiro +3 more·2000·Nature Genetics

Cited by (1,004)

Items 201–300 of 1,004

  1. Neurobiology and treatment of Parkinson's disease
    Anthony H.V. Schapira · 2008 · Trends in Pharmacological Sciences
  2. A Dimeric PINK1-containing Complex on Depolarized Mitochondria Stimulates Parkin Recruitment
    Kei Okatsu, Midori Uno, Fumika Koyano, Etsu Go, Mayumi Kimura, Toshihiko Oka, Keiji Tanaka, Noriyuki Matsuda · 2013 · Journal of Biological Chemistry
  3. The centrosome in human genetic disease
    José Luis Badano, Tanya M. Teslovich, Nicholas Katsanis · 2005 · Nature Reviews Genetics
  4. Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death
    Han Seok Ko, Rainer von Coelln, Sathya R. Sriram, Seong Who Kim, Kenny K. K. Chung, Olga Pletniková, Juan Carlos Troncoso, B. Lamar Johnson, Roya Saffary, Eyleen L. K. Goh et al. · 2005 · Journal of Neuroscience
  5. Role and Function of the 26S Proteasome in Proliferation and Apoptosis
    Cord Naujokat, Stephan Hoffmann · 2002 · Laboratory Investigation
  6. Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
    Madalena Martins, Alexandra Rosa, Leonor Correia Guedes, Benedita V. Fonseca, Kristina Gotovac, Sara Nunes Violante, Tiago Mestre, Miguel M Coelho, Mário Miguel Rosa, Eden R. Martin et al. · 2011 · PLoS ONE
  7. Apoptosis Signal-Regulating Kinase 1 in Stress and Immune Response
    Kohsuke Takeda, Takuya Noguchi, Isao Naguro, Hidenori Ichijo · 2007 · The Annual Review of Pharmacology and Toxicology
  8. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress
    Darren J. Moore, Li Zhang, Juan Carlos Troncoso, Michael K. Lee, Nobutaka Hattori, Yoshikuni Mizuno, Ted M. Dawson, Valina Lynn Dawson · 2004 · Human Molecular Genetics
  9. Cooperation of molecular chaperones with the ubiquitin/proteasome system
    Claudia Esser, Simon Alberti, Jörg Höhfeld · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  10. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain
    Eri Sakata, Yoshiki Yamaguchi, Eiji Kurimoto, Jun Kikuchi, Shigeyuki Yokoyama, Shingo Yamada, Hiroyuki Kawahara, Hideyoshi Yokosawa, Nobutaka Hattori, Yoshikuni Mizuno et al. · 2003 · EMBO Reports
  11. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration
    Olga Corti · 2003 · Human Molecular Genetics
  12. Hsp90-Cdc37 Chaperone Complex Regulates Ulk1- and Atg13-Mediated Mitophagy
    Joung Hyuck Joo, Frank Charles Dorsey, Aashish Joshi, Kristin M. Hennessy-Walters, Kristie Lindsey Rose, Kelly McCastlain, Ji Zhang, Rekha V. Iyengar, Chang Hwa Jung, Der‐Fen Suen et al. · 2011 · Molecular Cell
  13. Pathophysiological Roles of ASK1-MAP Kinase Signaling Pathways
    Hiroaki Nagai, Takuya Noguchi, Kohsuke Takeda, Hidenori Ichijo · 2007 · BMB Reports
  14. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
    Jiang, Houbo, Ren, Yong, Zhao, Jinghui, Feng, Jian · 2004 · Human Molecular Genetics
  15. Endoplasmic reticulum dysfunction – a common denominator for cell injury in acute and degenerative diseases of the brain?
    Wulf Paschen, Aase Frandsen · 2001 · Journal of Neurochemistry
  16. Rare genetic mutations shed light on the pathogenesis of Parkinson disease
    Ted M. Dawson, Valina Lynn Dawson · 2003 · Journal of Clinical Investigation
  17. Crystal Structures of Human DJ-1 and Escherichia coli Hsp31, Which Share an Evolutionarily Conserved Domain
    Sun‐Joo Lee, So Jung Kim, In-Kwon Kim, Junsang Ko, Chang‐Sook Jeong, Gyung-Hwa Kim, Chankyu Park, Sa-Ouk Kang, Pann‐Ghill Suh, Heung-Soo Lee et al. · 2003 · Journal of Biological Chemistry
  18. Neuroprotective Strategies in Parkinson???s Disease
    Silvia A. Mandel, Edna Grünblatt, Peter Franz Riederer, Manfred Gerlach, Yona Levites, Moussa B. H. Youdim · 2003 · CNS Drugs
  19. The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation
    Koji Yamano, Noriyuki Matsuda, Keiji Tanaka · 2016 · EMBO Reports
  20. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice
    George Poulogiannis, Rebecca E. McIntyre, Maria Dimitriadi, John Richard Apps, Catherine H. Wilson, Koichi Ichimura, Feijun Luo, Lewis C. Cantley, Andrew H. Wyllie, David J. Adams et al. · 2010 · Proceedings of the National Academy of Sciences
  21. L166P Mutant DJ-1, Causative for Recessive Parkinson's Disease, Is Degraded through the Ubiquitin-Proteasome System
    David W. Miller, Rili Ahmad, Stephen Hague, Melisa J. Baptista, Rosa Canet-Aviles, Chris McLendon, Donald M. Carter, Peng‐Peng Zhu, Julia Stadler, Jayanth S. Chandran et al. · 2003 · Journal of Biological Chemistry
  22. Are ubiquitination pathways central to Parkinson’s disease?
    Giasson, Benoit I, Lee, Virginia M.-Y · 2003 · Cell
  23. The diagnosis of manganese-induced parkinsonism
    Maria Graciela Cersosimo, William C. Koller · 2005 · NeuroToxicology
  24. iPS cell technologies: significance and applications to CNS regeneration and disease
    Hideyuki Okano, Shinya Yamanaka · 2014 · Molecular Brain
  25. Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1
    Glauser, Liliane, Sonnay, Sarah, Stafa, Klodjan, Moore, Darren J. · 2011 · Journal of Neurochemistry
  26. Evolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process
    Åsa B. Gustafsson, Gerald W. Dorn · 2018 · Physiological Reviews
  27. Recent advances in the genetics and pathogenesis of Parkinson disease
    M. Maral Mouradian · 2002 · Neurology
  28. Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca2+ transfer to sustain cell bioenergetics
    Tito Calí, Denis Ottolini, Alessandro Negro, Marisa Brini · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  29. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin–protein ligase with monoubiquitylation capacity
    Cornelia Hampe, Héctor Ardila-Osorio, Margot Fournier, Alexis Brice, Olga Corti · 2006 · Human Molecular Genetics
  30. Bcl-2 Family Proteins Participate in Mitochondrial Quality Control by Regulating Parkin/PINK1-Dependent Mitophagy
    Émilie Hollville, Richard G. Carroll, Sean P. Cullen, Séamus J. Martin · 2014 · Molecular Cell
  31. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin
    Sathya R. Sriram, Xiaojie Li, Han Seok Ko, Kenny K. K. Chung, Esther S.P. Wong, Kah Leong Lim, Valina Lynn Dawson, Ted M. Dawson · 2005 · Human Molecular Genetics
  32. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders
    Kenny K. K. Chung, Valina Lynn Dawson, Ted M. Dawson · 2001 · Trends in Neurosciences
  33. Pathogenic mutations in Parkinson disease
    Eng‐King Tan, Lisa M. Skipper · 2007 · Human Mutation
  34. The PARK8 Locus in Autosomal Dominant Parkinsonism: Confirmation of Linkage and Further Delineation of the Disease-Containing Interval
    Alexander A. Zimprich, Bertram Müller-Myhsok, Matthew James Farrer, Petra Leitner, Manu Sharma, Mary Hulihan, Paul J. Lockhart, Audrey J. Strongosky, Jennifer M. Kachergus, Donald B. Calne et al. · 2004 · The American Journal of Human Genetics
  35. Parkin as a tumor suppressor gene for hepatocellular carcinoma
    M Fujiwara, Hiroyuki Marusawa, H-Q Wang, A Iwai, K Ikeuchi, Yuzuru Imai, Ayane Kataoka, Nobuyuki Nukina, Rei Takahashi, Tsutomu Chiba · 2008 · Oncogene
  36. Modeling Parkinson’s Disease in C. elegans
    Jason F. Cooper, Jeremy M. Van Raamsdonk · 2018 · Journal of Parkinson s Disease
  37. CHIP: a quality-control E3 ligase collaborating with molecular chaperones
    Murata, Shigeo, Chiba, Tomoki, Tanaka, Keiji · 2003 · The International Journal of Biochemistry & Cell Biology
  38. Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease
    Sahabuddin Ahmed, Mohit Kwatra, Samir Ranjan Panda, U.S.N Murty, V.G.M. Naidu · 2020 · Brain Behavior and Immunity
  39. Amyloid‐fibril formation
    Eva Žerovnik · 2002 · European Journal of Biochemistry
  40. microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches
    Loredana Leggio, Silvia Vivarelli, Francesca L’Episcopo, Cataldo Tirolo, Salvatore Caniglia, Nunzio Testa, Bianca Marchetti, Nunzio Iraci · 2017 · International Journal of Molecular Sciences
  41. The genetic landscape of Parkinson's disease
    Ariane Lunati, Suzanne Lesage, Alexis Brice · 2018 · Revue Neurologique
  42. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI
    Duong P. Huynh · 2003 · Human Molecular Genetics
  43. Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease
    Sofia A. Oliveira, William K. Scott, Eden R. Martin, MARTHA A. NANCE, Ray L. Watts, Jean Pintar Hubble, William C. Koller, Rajesh Pahwa, Matthew B. Stern, Bradley C. Hiner et al. · 2003 · Annals of Neurology
  44. Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease
    Beisha Tang, Hui Xiong, Ping Sun, Yuhu Zhang, Danling Wang, Zhengmao Hu, Zan-Hua Zhu, Hong Ma, Qian Pan, Jiahui Xia et al. · 2006 · Human Molecular Genetics
  45. Ubiquitin–proteasome system and Parkinson's disease
    C. Warren Olanow, Kevin St. P. McNaught · 2006 · Movement Disorders
  46. Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
    Juan Liu, Cen Zhang, Yuhan Zhao, Xuetian Yue, Hao Wu, SHAN HU HUANG, James Chen, Kyle Tomsky, Haiyang Xie, Christen A. Khella et al. · 2017 · Nature Communications
  47. Advancement in the modelling and therapeutics of Parkinson’s disease
    Sachchida Nand, Payal Singh · 2020 · Journal of Chemical Neuroanatomy
  48. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson’s disease
    Imam, Syed Z., Zhou, Qing, Yamamoto, Ayako, Valente, Anthony J., Ali, Syed F., Bains, Mona, Roberts, James L., Kahle, Philipp J., Clark, Robert A., Li, Senlin · 2011 · The Journal of Neuroscience
  49. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
    Cristine Alvès da Costa, Claire Sunyach, Emilie Giaime, Andrew B. West, Olga Corti, Alexis Brice, Stephen H Safe, Patrick M. Abou‐Sleiman, Nicholas William Wood, Hitoshi Takahashi et al. · 2009 · Nature Cell Biology
  50. Mitophagy: Molecular Mechanisms, New Concepts on Parkin Activation and the Emerging Role of AMPK/ULK1 Axis
    Roberto Iorio, Giuseppe Celenza, Sabrina Petricca · 2021 · Cells
  51. Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
    Christine Klein, Michael G. Schlossmacher · 2007 · Neurology
  52. Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells
    Kye‐Young Kim, Mark V. Stevens, M. Hasina Akter, Sarah E. Rusk, Robert J. Huang, Alexandra Cohen, Audrey C. Noguchi, Danielle Springer, Alexander V. Bocharov, Tomas L. Eggerman et al. · 2011 · Journal of Clinical Investigation
  53. Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation
    Iguchi, Masahiro, Kujuro, Yuki, Okatsu, Kei, Koyano, Fumika, Kosako, Hidetaka, Kimura, Mayumi, Suzuki, Norihiro, Uchiyama, Shinichiro, Tanaka, Keiji, Matsuda, Noriyuki · 2013 · Journal of Biological Chemistry
  54. Dorfin Ubiquitylates Mutant SOD1 and Prevents Mutant SOD1-mediated Neurotoxicity
    Jun-ichi Niwa, Shinsuke Ishigaki, Nozomi Hishikawa, Masahiko Yamamoto, Manabu Doyu, Shigeo Murata, Keiji Tanaka, Naoyuki Taniguchi, Gen Sobue · 2002 · Journal of Biological Chemistry
  55. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain
    Neelima B. Chauhan, George J. Siegel, John Michael Lee · 2001 · Journal of Chemical Neuroanatomy
  56. The emerging role of nutrition in Parkinson's disease
    Stacey E. Seidl, José A. Santiago, Hope T. Bilyk, Judith A. Potashkin · 2014 · Frontiers in Aging Neuroscience
  57. Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease
    McNaught, Kevin St. P., Olanow, C. Warren · 2003 · Annals of Neurology
  58. The Ubiquitin-domain Protein HERP forms a Complex with Components of the Endoplasmic Reticulum Associated Degradation Pathway
    Andrea Schulze, Sybille Standera, Elke Buerger, Marjolein Kikkert, Sjaak van Voorden, Emmanuel J. H. J. Wiertz, Frits Koning, Peter‐Michael Kloetzel, Michael Seeger · 2005 · Journal of Molecular Biology
  59. Complex relationship between Parkin mutations and Parkinson disease
    Andrew B. West, Magali Periquet, Sarah Lincoln, Christoph B. Lücking, David Joseph Nicholl, Vincenzo Bonifati, Nina Rawal, Thomas Gasser, Ebba Lohmann, Jean‐François Deleuze et al. · 2002 · American Journal of Medical Genetics
  60. Mitochondrial dysfunction in Parkinson’s disease
    Qingsong Hu, Guanghui Wang · 2016 · Translational Neurodegeneration
  61. BAG5 Inhibits Parkin and Enhances Dopaminergic Neuron Degeneration
    Suneil Kumar Kalia, Sang Lee, Patrice D. Smith, Li Liu, Stephen J. Crocker, Thorhildur Thorarinsdottir, John R. Glover, Edward A. Fon, David S. Park, Andrés M. Lozano · 2004 · Neuron
  62. Hepatitis C Virus Induces the Mitochondrial Translocation of Parkin and Subsequent Mitophagy
    Seong‐Jun Kim, Gulam Hussain Syed, Aleem Siddiqui · 2013 · PLoS Pathogens
  63. PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson’s Disease Pathobiology?
    Truban, Dominika, Hou, Xu, Caulfield, Thomas R., Fiesel, Fabienne C., Springer, Wolfdieter · 2016 · Journal of Parkinson’s Disease
  64. Parkinson's disease and α‐synuclein expression
    Michael J. Devine, Katrina A. Gwinn, Andrew Singleton, John Hardy · 2011 · Movement Disorders
  65. Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
    Georgia S. Gaki, Athanasios G. Papavassiliou · 2014 · NeuroMolecular Medicine
  66. The role of α-synuclein in neurodegenerative diseases
    M. Catherine Bennett · 2004 · Pharmacology & Therapeutics
  67. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease
    Li Zuo, Michael S. Motherwell · 2013 · Gene
  68. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis
    Jessica C. Greene, Alexander J. Whitworth, Laurie A. Andrews, Tracey J. Parker, Leo J. Pallanck · 2005 · Human Molecular Genetics
  69. Mechanism of parkin activation by phosphorylation
    Véronique Sauvé, George Sung, Naoto Soya, Guennadi Kozlov, Nina Blaimschein, Lis Schwartz Miotto, Jean‐François Trempe, Gergely L. Lukács, Kalle Gehring · 2018 · Nature Structural & Molecular Biology
  70. Proteostasis and neurodegeneration: The roles of proteasomal degradation and autophagy
    Keiji Tanaka, Noriyuki Matsuda · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  71. Recent advances in p97/VCP/Cdc48 cellular functions
    Kunitoshi Yamanaka, Yohei Sasagawa, Teru Ogura · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  72. Genetics of Parkinsonʼs disease
    Thomas Gasser · 2005 · Current Opinion in Neurology
  73. Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading
    Reiko Nakao, Katsuya Hirasaka, Jumpei Goto, Kazumi Ishidoh, Chiharu Yamada, Ayako Ohno, Yuushi Okumura, Ikuya Nonaka, Koji Yasutomo, Kenneth M. Baldwin et al. · 2009 · Molecular and Cellular Biology
  74. Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition
    Francesco Fornai, Paola Lenzi, Marco Gesi, Michela Ferrucci, Gloria Lazzeri, Carla Letizia Busceti, Riccardo Ruffoli, Paola Soldani, Stefano A. Ruggieri, M. Alessandri et al. · 2003 · Journal of Neuroscience
  75. Parkin and CASK/LIN-2 Associate via a PDZ-mediated Interaction and Are Co-localized in Lipid Rafts and Postsynaptic Densities in Brain
    Lara Fallon, France Moreau, Benjamin G. Croft, Noura Labib, Wen‐Jie Gu, Edward A. Fon · 2002 · Journal of Biological Chemistry
  76. Cell death: protein misfolding and neurodegenerative diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2009 · APOPTOSIS
  77. The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax
    Bethann N. Johnson, Alison K. Berger, Giuseppe P. Cortese, Matthew J. LaVoie · 2012 · Proceedings of the National Academy of Sciences
  78. Targets for neuroprotection in Parkinson's disease
    Talene A. Yacoubian, David G. Standaert · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  79. Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons
    Mian Cao, Yumei Wu, Ghazaleh Ashrafi, Amber J. McCartney, Heather Wheeler, Eric A. Bushong, Daniela Boassa, Mark H. Ellisman, Timothy A. Ryan, Pietro V. De Camilli · 2017 · Neuron
  80. Parkin genetics: one model for Parkinson's disease
    Ignacio Fernandez Mata · 2004 · Human Molecular Genetics
  81. Deubiquitinating enzymes--the importance of driving in reverse along the ubiquitin-proteasome pathway.
    Simon S. Wing · 2003 · International Journal of Biochemistry and Cell Biology
  82. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio)
    L. Flinn, Heather Mortiboys, Katrin Volkmann, Reinhard Wolfgang Köster, Philip William Ingham, Oliver Bandmann · 2009 · Brain
  83. Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
    Michael S. Levine, Carlos Cepeda, Miriam Ann Hickey, Sheila M. Fleming, Marie‐Françoise Chesselet · 2004 · Trends in Neurosciences
  84. Identification of the ubiquitin–protein ligase that recognizes oxidized IRP2
    Yamanaka, Koji, Ishikawa, Haruto, Megumi, Yuzuru, Tokunaga, Fuminori, Kanie, Masato, Rouault, Tracey A., Morishima, Isao, Minato, Nagahiro, Ishimori, Koichiro, Iwai, Kazuhiro · 2003 · Nature Cell Biology
  85. Genes, proteins, and neurotoxins involved in Parkinson’s disease
    Oliver von Bohlen und Halbach, Andreas Schober, Kerstin G. KRIEGLSTEIN · 2004 · Progress in Neurobiology
  86. PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation
    Graeme Sargent, Tim van Zutphen, Tatiana Shatseva, Ling Zhang, Valeria Di Giovanni, Robert Bandsma, Peter Kijun Kim · 2016 · The Journal of Cell Biology
  87. The role of mitochondria in inherited neurodegenerative diseases
    Kwong, Jennifer Q., Beal, M. Flint, Manfredi, Giovanni · 2006 · Journal of Neurochemistry
  88. Endoplasmic reticulum: a primary target in various acute disorders and degenerative diseases of the brain
    Wulf Paschen · 2003 · Cell Calcium
  89. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
    Victorio M. Pozo Devoto, Tomás Luis Falzone · 2017 · Disease Models & Mechanisms
  90. The ubiquitin system, disease, and drug discovery
    Matthew D. Petroski · 2008 · BMC Biochemistry
  91. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair
    Oliver C. Rothfuss, Heike Fischer, Takafumi Hasegawa, Martina Maisel, Petra Leitner, Franziska Miesel, Manu Sharma, Antje Bornemann, Daniela Berg, Thomas Gasser et al. · 2009 · Human Molecular Genetics
  92. Drosophila Nedd4, a Ubiquitin Ligase, Is Recruited by Commissureless to Control Cell Surface Levels of the Roundabout Receptor
    Anna Myat, Pauline Henry, Veronica M. McCabe, Louisa Flintoft, Daniela Rotin, Guy Tear · 2002 · Neuron
  93. Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
    Yongxing Gong, Travis Ian Zack, Luc G.T. Morris, Kan Lin, Ellen Hukkelhoven, Radhika Raheja, I‐Li Tan, Şevin Turcan, Selvaraju Veeriah, Shasha Meng et al. · 2014 · Nature Genetics
  94. Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology
    Shaobin Yu, Ling Zhu, Qiang Shen, Xue Bai, Xuhui Di · 2015 · Behavioural Neurology
  95. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases
    Wim J. Mandemakers, Vanessa A. Morais, Bart De Strooper · 2007 · Journal of Cell Science
  96. Mitochondrial Dysfunction in Parkinson's Disease
    Paul C. Keane, Marzena Kurzawa‐Akanbi, Peter G. Blain, Christopher M. Morris · 2011 · Parkinson s Disease
  97. Neuroinflammation in Parkinson’s Disease
    Jae‐Kyung Lee, Thi Anh Thu Tran, Malú G. Tansey · 2009 · Journal of Neuroimmune Pharmacology
  98. Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea
    Hélène Plun‐Favreau, Patrick Alfryn Lewis, John Hardy, L. Miguel Martins, Nicholas William Wood · 2010 · PLoS Genetics
  99. Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics
    Yong Feng Zhou, Guangyu Gu, David R. Goodlett, Terry Zhang, Catherine Pan, Thomas Jude Montine, Kathleen S. Montine, Ruedi H. Aebersold, Jing Zhang · 2004 · Journal of Biological Chemistry
  100. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
    Vivekanantham, Sayinthen, Shah, Savan, Dewji, Rizwan, Dewji, Abbas, Khatri, Chetan, Ologunde, Rele · 2015 · International Journal of Neuroscience